|
ZNF527 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44089209850063E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88737914186277E-15 |
| Normal-vs-Stage2 |
6.41020569958073E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.720200E-01 |
| Stage1-vs-Stage3 |
5.897800E-02 |
| Stage1-vs-Stage4 |
2.461300E-03 |
| Stage2-vs-Stage3 |
2.648300E-02 |
| Stage2-vs-Stage4 |
1.881430E-03 |
| Stage3-vs-Stage4 |
2.475600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.33540000168964E-08 |
| Normal-vs-Asian |
8.22675261247241E-14 |
| Caucasian-vs-AfricanAmerican |
3.580200E-01 |
| Caucasian-vs-Asian |
2.366800E-01 |
| AfricanAmerican-vs-Asian |
9.635200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.62492241884138E-12 |
| Male-vs-Female |
9.317400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(41-60Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62814206561279E-12 |
| Normal-vs-Age(81-100Yrs) |
3.8646000000031E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.790000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.279800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.077600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.519200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.918800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.725800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.52800000044573E-07 |
| Classical-VS-Follicular |
1.235700E-02 |
| Classical-VS-Other |
8.347800E-01 |
| Classical-VS-Normal |
4.66293670342566E-15 |
| Tall-VS-Follicular |
4.36320002350499E-09 |
| Tall-VS-Other |
1.293370E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.411400E-01 |
| Follicular-VS-Normal |
4.21751522594604E-12 |
| Other-VS-Normal |
1.564050E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62814206561279E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.523100E-03 |
|
|
